Jennifer L. Reichek, MD, MSW

Biography

  • Attending Physician, Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Director, STAR Program (Survivors Taking Action and Responsibility), Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Hematology/Oncology, Children's Hospital of Philadelphia 2005-2008
  • Residency in Pediatrics, Children's Hospital of Philadelphia 2002-2005
  • MD, MCP Hahnemann University College of Medicine 2002

Clinical Studies

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Recruiting

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Recruiting

Neuroblastoma Biology Study

Recruiting

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Publications

Jan. 10, 2024

Guidelines for Standardization of Pediatric Anthracycline Cardiomyopathy Echocardiogram Surveillance-A Call for Harmonization in the Field to Enhance Research in the Cancer Survivor Population.

Aug. 04, 2023

Utilization of Teleconsent for Adolescent and Young Adult Cancer Clinical Trials, a Report from the Children's Oncology Group.

Jul. 20, 2023

Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).

See all publications

Similar Researchers

Clinical and Community Trials

Angela Waanders, MD, MPH

Recent Publication

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Nov. 17, 2023
Community, Population Health, and Outcomes

Jennifer Kusma Saper, MD, MS

Research Interests

Health care policy, Health services research, Medicaid, Advocacy, Health equity

Recent Publication

Medicaid and the Children's Health Insurance Program: Optimization to Promote Equity in Child and Young Adult Health.

Oct. 20, 2023
Basic and Preclinical Science

Kevin McNerney, MD

Research Interests

CAR T-cell Therapy, CAR T-cell Toxicities, Immunotherapy, Hematopoietic Stem Cell Transplant, Leukemia

Recent Publication

Mediport use as an acceptable standard for CAR T cell infusion.

Oct. 27, 2023
Clinical and Community Trials

Jarrett R. Linder, MD

Recent Publication

Novel Utilization of Ultrasound Enhancing Agents in Complex Congenital Heart Disease Following Superior Cavopulmonary Connection.

Jan. 13, 2023

Duri Yun, MD, MPH

Recent Publication

Restrictive dermopathy: Three new patients with ZMPSTE24 mutations and a review of the literature.

Oct. 14, 2021

Brian Wolfe, MD